Insider Transactions in Q1 2021 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,224
-17.52%
|
$1,577,904
$71.19 P/Share
|
|
Mar 31
2021
|
Roy Winston Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+22.08%
|
$467,500
$34.38 P/Share
|
|
Mar 24
2021
|
David M Stack CEO and Chairman |
SELL
Bona fide gift
|
Indirect |
1,080
-1.1%
|
-
|
|
Mar 17
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,000
-13.17%
|
$140,000
$70.01 P/Share
|
|
Mar 17
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.64%
|
$20,000
$10.81 P/Share
|
|
Mar 15
2021
|
Mark Froimson Director |
SELL
Open market or private sale
|
Direct |
734
-12.28%
|
$52,848
$72.26 P/Share
|
|
Mar 15
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,520
-10.34%
|
$110,960
$73.28 P/Share
|
|
Mar 15
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
1,520
+9.37%
|
$15,200
$10.81 P/Share
|
|
Mar 15
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
10,601
-2.3%
|
$773,873
$73.68 P/Share
|
|
Mar 12
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
58,754
-11.28%
|
$4,289,042
$73.1 P/Share
|
|
Mar 11
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
60,574
-10.42%
|
$4,361,328
$72.7 P/Share
|
|
Mar 10
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
76,480
-11.63%
|
$5,430,080
$71.78 P/Share
|
|
Mar 09
2021
|
Andreas Wicki Director |
SELL
Open market or private sale
|
Indirect |
35,137
-5.07%
|
$2,459,590
$70.9 P/Share
|
|
Mar 05
2021
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
3,000
-32.91%
|
$195,000
$65.88 P/Share
|
|
Mar 05
2021
|
Paul J Hastings Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+24.76%
|
$39,000
$13.98 P/Share
|
|
Mar 01
2021
|
John P Phd Longenecker Director |
SELL
Open market or private sale
|
Direct |
5,000
-21.97%
|
$360,000
$72.26 P/Share
|
|
Mar 01
2021
|
John P Phd Longenecker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+18.01%
|
$65,000
$13.98 P/Share
|
|
Feb 03
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
21,250
-11.48%
|
$1,508,750
$71.1 P/Share
|
|
Feb 03
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+17.92%
|
$212,500
$10.81 P/Share
|
|
Feb 02
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
21,250
-7.73%
|
$1,466,250
$69.33 P/Share
|
|
Feb 02
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+17.92%
|
$212,500
$10.81 P/Share
|
|
Jan 06
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
110
-0.78%
|
$6,600
$60.81 P/Share
|